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Abstract: The developmental neurotoxicity of organophosphates involves 
mechanisms other than their shared property as cholinesterase inhibitors, 
among which are excitotoxicity and oxidative stress. We used PC12 cells as a 
neurodevelopmental model to compare the effects of chlorpyrifos and 
diazinon on the expression of genes encoding glutamate transporters. 
Chlorpyrifos had a greater effect in cells undergoing nerve growth factor-
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induced neurodifferentiation as compared to undifferentiated PC12 cells, with 
peak sensitivity at the initiation of differentiation, reflecting a global 
upregulation of all the glutamate transporter genes expressed in this cell line. 
In differentiating cells, chlorpyrifos had a significantly greater effect than did 
diazinon and concordance analysis indicated no resemblance in their 
expression patterns. At the same time, the smaller effects of diazinon were 
highly concordant with those of an organochlorine pesticide (dieldrin) and a 
metal (divalent nickel). We also performed similar evaluations for the 
cystine/glutamate exchanger, which provides protection against oxidative 
stress by moving cystine into the cell; again, chlorpyrifos had the greatest 
effect, in this case reducing expression in undifferentiated and differentiating 
cells. Our results point to excitotoxicity and oxidative stress as major 
contributors to the noncholinesterase mechanisms that distinguish the 
neurodevelopmental outcomes betweem different organophosphates while 
providing a means whereby apparently unrelated neurotoxicants may produce 
similar outcomes. 
Keywords: Chlorpyrifos, Diazinon, Dieldrin, Gene transcription patterns, 
Glutamate transporters, Microarrays, Nickel, Organochlorine insecticides, 
Organophosphate insecticides, PC12 cells 
Introduction 
Organophosphates are the most widely-used insecticides but are 
undergoing increasing scrutiny because of their propensity to elicit 
developmental neurotoxicity [10,11,16,35,47]. As predicted by the 
results of laboratory studies over the past two decades, recent 
evaluations in human populations confirm a specific relationship 
between exposure to organophosphates and neurodevelopmental 
delays, depression and attention deficit hyperactivity disorder 
[6,7,24,42]. Originally, it was thought that these agents acted solely 
through inhibition of cholinesterase, so that exposure and toxicity 
could both be monitored readily by measuring the activity of this 
enzyme in plasma or red blood cells [36]. However, it is increasingly 
evident that organophosphates produce neurodevelopmental deficits 
below the threshold for signs of exposure or even without a detectable 
reduction in cholinesterase [11,47]. If organophosphates act through 
mechanisms other than their shared anticholinesterase properties, the 
various members of this class may differ in their ability to act as 
developmental neurotoxicants, and it then becomes important to 
identify the degree to which the different organophosphates target 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Brain Research Bulletin, Vol. 83, No. 1-2 (August 2010): pg. 76-83. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
3 
 
those mechanisms. We recently showed that chlorpyrifos and diazinon, 
two of the most commonly-used organophosphates, differ substantially 
in their ability to elicit oxidative stress or excitotoxicity, with 
chlorpyrifos producing much larger changes in ionotropic glutamate 
receptor gene expression, whereas diazinon evoked greater effects on 
genes involved in apoptosis [50,54]. A subsequent paper pointed to 
further differences directed toward glutamate uptake and release and 
suggested the need to evaluate their comparative effects on glutamate 
transporters [44], the subject of the current study. 
Our evaluations were conducted in PC12 cells, a widely-used in 
vitro model for neuronal development [64] that reproduces the 
mechanisms and outcomes of in vivo organophosphate exposures 
[3,4,13–15,18,25,26,33,37,39,40,49,50,59,60,62,66]. Nerve growth 
factor triggers differentiation of PC12 cells into neuronal phenotypes 
[20,62,64] and, like neurons, PC12 cells express the family of 
glutamate transporters that play an important role in the response to 
excitotoxic injury and oxidative stress, recapitulating the same 
functions as in the central nervous system [1,19,27,30,31,68]. 
Similarly, PC12 cells also possess the cystine/glutamate exchanger, 
which provides antioxidant protection by moving cystine into the cell in 
return for moving glutamate outwards [38]. 
For chlorpyrifos, we evaluated the effects in the undifferentiated 
state and during differentiation; we then compared the effects during 
differentiation with those of diazinon. Finally, we contrasted the effects 
of the organophosphates with those unrelated developmental 
neurotoxicants, the organochlorine insecticide, dieldrin, and a metal, 
divalent nickel. In our earlier work, we unexpectedly found similarities 
between their effects and those of organophosphates with regard to 
oxidative stress, excitotoxicity, cell signaling, neurotrophic responses 
and neurodifferentiation [2,50,53–57,60]. These additional test agents 
have intrinsic interest because of environmental concerns about 
human exposure and safety. Dieldrin is known to produce 
developmental neurotoxicity [8,28,29,34,50,67]; nickel shows fetal 
accumulation similar to that of lead [9,23] and shares neurotoxic 
actions with lead and cadmium [5]. For our evaluations, we used 
microarrays in a “planned comparisons” framework, where genes are 
selected based on a specific pathway and hypothesis prior to 
examining the microarray data, rather than the other way around; the 
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advantages and limitations of this approach as compared to searches 
of the entire genome have been presented previously [52,56,58–60]. 
Here, we restricted our examination to the glutamate transporter 
family. In addition to examining up- and downregulation of the 
glutamate transporter genes, we also assessed concordance between 
pairs of agents to determine overall similarities of the transcriptional 
responses [2,54,60]. 
Methods 
Cell cultures 
Because of the clonal instability of the PC12 cell line [20], the 
experiments were performed on cells that had undergone fewer than 
five passages. As described previously [41,62], PC12 cells (American 
Type Culture Collection, CRL-1721, obtained from the Duke 
Comprehensive Cancer Center, Durham, NC) were seeded onto poly-
D-lysine-coated plates in RPMI-1640 medium (Invitrogen, Carlsbad, 
CA) supplemented with 10% horse serum (Sigma Chemical Co., St. 
Louis, MO), 5% fetal bovine serum (Sigma), and 50 μg/ml penicillin 
streptomycin (Invitrogen). Incubations were carried out with 7.5% CO2 
at 37°C, standard conditions for PC12 cells. To initiate 
neurodifferentiation [25,50,64] twenty-four hours after seeding, the 
medium was changed to include 50 ng/ml of 2.5 S murine nerve 
growth factor (Invitrogen). Along with the nerve growth factor, we 
added 30 μM of each of the test agents: chlorpyrifos (Chem Service, 
West Chester, PA), diazinon (Chem Service), dieldrin (Chem Service) 
or NiCl2 (Sigma). The concentration was chosen from earlier studies 
that demonstrated adverse effects on differentiation of PC12 cells 
without outright cytotoxicity [26,39,50,59]. Because of the limited 
water solubility of the three insecticides, these agents were dissolved 
in dimethylsulfoxide (final concentration 0.1%), which was also added 
to the control cultures and to cultures containing NiCl2; this 
concentration of dimethylsulfoxide has no effect on PC12 cell growth or 
differentiation [39,41,62]. Cultures were examined 24 and 72 hr after 
commencing exposure, with 5–8 independent cultures evaluated for 
each treatment at each time point. Each culture was run on a separate 
array. We used two time points so as to be able to evaluate changes in 
gene expression regardless of whether the mRNA for a given gene has 
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a rapid turnover (and hence can rise rapidly) or a slower turnover that 
would require a longer period to show corresponding increases or 
decreases. For chlorpyrifos, we evaluated the effects both on 
undifferentiated cells (without addition of nerve growth factor) and 
during differentiation, whereas for the other agents, we studied the 
effects only during differentiation. 
Microarray determinations 
Our earlier studies detailed the techniques for mRNA isolation, 
preparation of cDNA, conversion to cRNA incorporating cyanine-3 
(reference RNA) or cyanine-5 (sample RNA), verification of RNA purity 
and quality, hybridization to the microarrays, washing and scanning 
[52,58,59]. These all involve commercial kits and standardized 
procedures, and since the current studies were done identically, the 
techniques will not be described here. The mRNA used for the 
reference standard was created by pooling aliquots from each of the 
samples in the study so as to ensure measurable levels of all genes 
expressed over the background. Array normalizations and error 
detection were also carried out by standard procedures described 
previously [52,58,59]. We used Agilent Whole Rat Genome Arrays 
(Agilent Technologies, Palo Alto, CA), type G4131A for the studies of 
chlorpyrifos in undifferentiated and differentiating cells, whereas type 
G4131F was used for the studies of diazinon, dieldrin and Ni2+ in 
differentiating cells. The two chips contain exactly the same gene 
sequences but the latter has a lower detection threshold; however, all 
the genes reported here passed the quality control filters with both 
arrays. 
For several of the genes, the arrays contain multiple probes 
and/or replicates of the same probe in different locations on the chip, 
and these were used to verify the reliability of values and the validity 
of the measures on the chip. In these cases, to avoid artificially 
inflating the number of genes utilized for analysis, we limited each 
gene to a single set of values, selecting those obtained for the probe 
showing the smallest intragroup variance. The other values for that 
gene were used only to corroborate direction and magnitude of 
change. We also validated the readings on the arrays through the use 
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of duplicate arrays for one sample selected from each treatment group 
[52,58]. 
Statistical procedures 
Because of the requirement to normalize the data across arrays, 
the absolute values for a given gene are meaningless, so only the 
relative differences between treatments can be compared. Our design 
involved planned comparisons of four agents at two time points, as 
well as the effects of one agent (chlorpyrifos) in undifferentiated vs. 
differentiating states. It was therefore important to protect against the 
increased probability of type 1 errors engendered by repeated testing 
of the same data base. Accordingly, before looking at effects on 
individual genes, we performed a global ANOVA incorporating all the 
variables in a single comparison: treatment, time, and all genes. 
Lower-order ANOVAs on subdivisions of the data set were then carried 
out as permitted by the interactions of treatment with the other 
variables. Differences for individual treatments for a specified gene at 
a single time point were evaluated with Fisher’s Protected Least 
Significant Difference. However, for a given gene where there was no 
interaction of treatment with other variables (time, differentiation 
state), only the main treatment effect was reported without subtesting 
of effects at a single time point. Treatment effects were considered 
significant at p < 0.05 (two-tailed, since we were interested in both 
increases and decreases in gene expression). 
To compare overall patterns of effects on gene expression, as 
distinguished from just identifying individual genes targeted by the 
treatments, we evaluated concordance between treatments by plotting 
the percentage change from control and calculating the linear 
correlation coefficient between pairs of agents [2,54,60]. 
Results 
The microarrays revealed significant expression of eight 
glutamate transporters that passed the quality control procedures 
(Table 1), including those related to neurons (slc1a1), synaptic 
vesicles (vglut3) and glia (slc1a2, slc1a3), as well as those 
transporting glutamate into multiple cell types (slc1a7), glutamate as 
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a neutral amino acid (slc1a4, slc1a5) or aspartate/glutamate (slc1a6). 
In addition, we were able to measure expression of the 
cystine/glutamate exchanger (slc7a11), which we considered 
separately from the glutamate transporter family. Because only one 
agent (chlorpyrifos) was tested in both undifferentiated and 
differentiating cells, we conducted two sets of global statistical tests. 
For chlorpyrifos, the ANOVA factors were treatment, differentiation 
state, time and gene, and we found a main treatment effect (p < 
0.007) as well as interactions of treatment × differentiation state × 
time (p < 0.03), treatment × time (p < 0.04) and treatment × time × 
gene (p < 0.02). Accordingly, we subdivided the results for 
presentation according to differentiation state and performed lower-
order tests to identify main effects and interactions with the remaining 
variables (time, gene). Diazinon, dieldrin and Ni2+ were studied only in 
differentiating cells, so the ANOVA factors for these agents were 
treatment, gene and time. The global test identified significant 
interactions of treatment × time (p < 0.02) and treatment × gene × 
time (p < 0.009), so we subdivided the data into the individual 
treatments for presentation and lower-order tests. 
 
In undifferentiated cells, chlorpyrifos elicited selective changes 
in the expression of glutamate transporter genes (Figure 1). There was 
a robust but transient increase in slc1a3 and smaller, but more 
sustained increases for slc1a4 and slc1a5, whereas vglut3 was 
decreased. The pattern was quite different for cells undergoing 
differentiation (Figure 2A). Here, chlorpyrifos evoked a significant, 
global upregulation (main treatment effect) that was significantly 
greater at 24h of exposure than at 72h (treatment × time interaction) 
but that was nevertheless statistically significant at either of the time 
points. Diazinon had a much smaller effect on glutamate transporter 
gene expression than did chlorpyrifos (Figure 2B). There was no 
global, main treatment effect but rather, there were smaller, gene- 
and time-specific changes confined to slc1a4 (transient increase), 
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slc1a5 (small but consistent increase) and vglut3 (decrease at 72h). 
Likewise, dieldrin (Figure 2C) had only small effects limited to a single 
significant change (slc1a5), as did Ni2+ (Figure 2D), which affected the 
same gene. 
 
Figure 1 Effects of chlorpyrifos exposure on expression of genes for glutamate 
transporters in undifferentiated PC12 cells. Multivariate ANOVA appears at the top of 
the panel and asterisks shown below each gene denote a significant main treatment 
effect; daggers denote genes for which a treatment × time interaction was detected 
and show the individual times for which treatment effects were present. Expression 
ratios in the control group were: slc1a1, 1.12 ± 0.05 at 24h, 1.25 ± 0.06 at 72h; 
slc1a2, 1.04 ± 0.08 at 24h, 0.99 ± 0.12 at 72h; slc1a3, 0.72 ± 0.06 at 24h, 1.28 ± 
0.09 at 72h; slc1a4, 0.80 ± 0.07 at 24h, 0.96 ± 0.08 at 72h; slc1a5, 0.84 ± 0.01 at 
24h, 0.90 ± 0.01 at 72h; slc1a6, 0.86 ± 0.07 at 24h, 1.03 ± 0.06 at 72h; slc1a7, 
0.99 ± 0.06 at 24h, 1.04 ± 0.06 at 72h; vglut3, 1.18 ± 0.09 at 24h, 1.05 ± 0.10 at 
72h. 
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Figure 2 Effects of different neurotoxicants on genes for glutamate transporters in 
differentiating PC12 cells: (A) chlorpyrifos, (B) diazinon, (C) dieldrin, (D) Ni2+. 
Multivariate ANOVA appears at the top of each panel. Where there was a significant 
difference in the treatment effects on the various genes (B,C,D), asterisks shown 
below each gene denote a significant main treatment effect; daggers denote genes for 
which a treatment × time interaction was detected and show the individual times for 
which treatment effects were present. Where there was only a treatment effect and 
interaction of treatment × time (A), the treatment effects for each time are shown 
within the legend box. Expression ratios in the control group were: slc1a1, 0.79 ± 
0.08 at 24h, 0.94 ± 0.10 at 72h; slc1a2, 1.16 ± 0.09 at 24h, 1.36 ± 0.10 at 72h; 
slc1a3, 0.57 ± 0.06 at 24h, 0.95 ± 0.08 at 72h; slc1a4, 0.83 ± 0.09 at 24h, 1.09 ± 
0.08 at 72h; slc1a5, 1.13 ± 0.04 at 24h, 0.99 ± 0.03 at 72h; slc1a6, 0.87 ± 0.09 at 
24h, 0.84 ± 0.02 at 72h; slc1a7, 0.98 ± 0.03 at 24h, 0.96 ± 0.04 at 72h; vglut3, 1.12 
± 0.06 at 24h, 0.93 ± 0.08 at 72h. 
To verify that the greater effects of chlorpyrifos in the 
differentiating cells were not solely dependent on the one 
determination showing the largest increase (slc1a3 at 24h), we 
performed paired comparisons using the Wilcoxon signed-rank test so 
as to give equal weight to the differences between treatments for each 
gene regardless of the absolute magnitude of the individual effect. 
Chlorpyrifos exposure in differentiating cells had a greater net effect 
than in undifferentiated cells (p < 0.008). Similarly, chlorpyrifos had a 
greater effect than diazinon (p < 0.005), dieldrin (p < 0.03) or Ni2+ (p 
< 0.003), whereas comparisons among the other three agents showed 
no significant distinction from each other. We further examined 
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similarities and differences among the treatments by evaluating the 
pairwise concordance across all the gene and time measurements; this 
procedure assesses patterns of effects incorporating all genes and time 
points, regardless of whether the effects were individually significant. 
Although there was a significant correlation between effects of 
chlorpyrifos in undifferentiated vs. differentiating cells, the entire 
relationship depended on a single measurement out of the 16 values, 
making it unlikely that the responses were biologically related (Figure 
3A). Similarly, there was no detectable relationship between the 
pattern of effects for chlorpyrifos in differentiating cells vs. either 
diazinon (Figure 3B), dieldrin (Figure 3C) or Ni2+ (Figure 3D). On the 
other hand, there was highly-significant concordance between the 
effects of diazinon and dieldrin (Figure 4A), diazinon and Ni2+ (Figure 
4B) and dieldrin and Ni2+ (Figure 4C). 
 
Figure 3 Pairwise correlations of the effects of chlorpyrifos in undifferentiated vs. 
differentiating cells (A), and in differentiating cells for chlorpyrifos vs. diazinon (B), 
dieldrin (C) or Ni2+ (D). In (A), a single point (slc1a3 at 1h, arrow) is responsible for 
the significant correlation; without that point, R = 0.20, not significant (NS). 
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Figure 4 Pairwise correlations of the effects of diazinon vs. dieldrin (A), diazinon 
vs. Ni2+ (B) and dieldrin vs. Ni2+ (C) in differentiating cells. Linear correlation 
coefficients are shown at the top of each panel along with the least-squares fit. 
Chlorpyrifos also had greater effects than the other agents 
toward expression of slc7a11, the cystine/glutamate exchanger (Figure 
5). For this gene, undifferentiated cells showed strong and persistent 
suppression by chlorpyrifos whereas the differentiating cells were 
affected to a smaller, but still significant degree. None of the other 
agents suppressed slc7a11 expression and indeed, dieldrin evoked a 
significant increase at 72h. 
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Figure 5 Effects of neurotoxicants on expression of the cystine/glutamate 
exchanger, slc7a11. Multivariate ANOVA indicates a significant main treatment effect 
(p < 0.0007) and a treatment × time interaction (p < 0.02). Asterisks denote 
treatments showing a main effect compared to control; the dagger denotes a 
significant treatment × time interaction and shows the individual time for which the 
treatment effect was present. Expression ratios in the control group were: 
undifferentiated cells, 2.09 ± 0.10 at 24h, 1.43 ± 0.15 at 72h; differentiating cells, 
1.47 ± 0.12 at 24h, 0.92 ± 0.09 at 72h. 
Discussion 
Results obtained in this study reinforce the idea that, despite 
their shared property as cholinesterase inhibitors, organophosphates 
can differ substantially in their ability to evoke developmental 
neurotoxicity through noncholinesterase mechanisms [10,12,22,47]. 
Here, we identified effects involving the glutamate transporters found 
in the synaptic cell membrane (the seven slc1a genes) and that are 
thus responsible for removing extracellular glutamate, as well as one 
of the vesicular transporters (vglut3) that moves glutamate from the 
cytoplasm into synaptic vesicles; these transporters are among the 
most important factors that limit excitotoxicity resulting from 
glutamate release. We found a much greater effect of chlorpyrifos than 
diazinon, a result is in keeping with distinctions between the two 
organophosphates in their impact on ionotropic glutamate receptors 
[54] and in the response to NMDA receptor antagonists, which protect 
cells from chlorpyrifos but not diazinon [44]. It is particularly notable 
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that the effects of chlorpyrifos on glutamate transporters was greatest 
during the early stages of neurodifferentiation; in our previous work 
with ionotropic glutamate receptors, we found greater sensitivity for 
undifferentiated PC12 cells. This dichotomy implies that chlorpyrifos-
induced excitotoxicity is likely to involve an extended range of 
developmental stages but with different underlying mechanisms for 
each stage. Indeed, the existence of such multiple mechanisms is one 
of the reasons that the developing brain is vulnerable to disruption by 
chlorpyrifos virtually throughout development, from the neural tube 
stage through late synaptic modeling and gliogenesis [46,47]. 
Although chlorpyrifos caused global upregulation of glutamate 
transporter gene expression, it downregulated the gene encoding the 
cystine/glutamate exchanger (slc7a11) in both undifferentiated and 
differentiating PC12 cells, but with greater effects in the former. 
Clearly, then, this involves a distinctly different mechanism from that 
mediating the effect on the transporters and more closely resembles 
the prior results for ionotropic glutamate receptors [54]. The 
cystine/glutamate exchanger moves cystine into the cell and 
glutamate out, with the subsequent intracellular formation of 
glutathione providing an important component of antioxidant defense. 
Organophosphates elicit oxidative stress as one of their 
noncholinesterase mechanisms of neurotoxicity [21,22,50,54,57] and 
hence, suppression of the exchanger could easily impair the ability of 
neuronal cells to withstand exposure. We are currently examining the 
function of the exchanger in primary mouse cortical cultures and, as 
predicted from the transcriptional effects seen here, our preliminary 
data indicate a clear-cut suppression of activity in response to an 
otherwise nontoxic, 24h chlorpyrifos exposure, (17 ± 4 percent 
reduction in [14C]cystine uptake, p < 0.006, n=20). Impaired 
cystine/glutamate exchange is particularly important in the developing 
brain because it has lower reserves of antioxidants [22], and is 
deficient in glia, which ordinarily protect neurons from oxidative 
molecules [63], while facing the higher metabolic demand associated 
with growth. Further, the fetal environment is hypoxic relative to that 
of the neonate or adult [17,32], thus fostering the conditions for 
oxidative stress. Again, chlorpyrifos was far more active than diazinon 
in downregulating the cystine/glutamate exchanger, potentially 
exacerbating the consequences of its effects on oxidative stress, as 
well as on glutamate release and transport. 
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Although it might be expected that chlorpyrifos and diazinon 
would be the most similar of the four toxicants evaluated here, we 
actually found that the effects of diazinon more closely resembled 
those of dieldrin and Ni2+. For the glutamate transporters, there was 
highly-significant concordance among diazinon, dieldrin and Ni2+ but 
not for any of these agents with chlorpyrifos. This continues a pattern 
that we identified in earlier studies comparing organophosphates to 
other toxicants with regard to oxidative stress, cell signaling cascades, 
neurotrophins and their receptors and neurodifferentiation endpoints 
[2,50,53–57,60]. The conclusion is inescapable: apparently unrelated 
developmental neurotoxicants can nevertheless converge on quite 
similar downstream mechanisms of neurotoxicity, despite any 
underlying differences in their chemical composition or initial 
mechanism. In turn, this implies that any single specific mechanism of 
action may be less important for neurotoxic outcomes than 
examination of downstream events known to participate in 
neurotoxicity. At the same time, it should then be possible to design 
countermeasures that can ameliorate or prevent neurotoxicity from 
otherwise disparate neurotoxicants by focusing on the downstream 
targets. 
In this study, we used planned comparisons of specific pathways 
targeted by the neurotoxicants and analyzed the data through the 
determination of shared properties (i.e. a standard “principal 
components” approach); the rationale for this has appeared previously 
[52,58,59] but is worth repeating here. Planned comparisons and 
pathway analysis are distinct from the use of microarrays to find a 
handful of genes that are affected the most, within the global 
examination of the tens of thousands of genes present on the 
microarrays. Planned comparisons are based instead on testing a 
specific hypothesis that centers around a defined set of genes, and 
rests on known, validating outcomes from prior work, in this case for 
the organophosphates. With examination of the entire genome, 
verification via RT-PCR and other techniques is required because the 
enormous number of comparisons generates many false positive 
findings (e.g. the >2000 genes that would be false positives if we had 
considered all 42,000 probes on the array). For our study, we 
compared only a few genes that would generate less than a single 
false positive, and for interpretation, we relied on concordance 
patterns to evaluate the overall spectrum of multiple gene changes for 
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each agent, rather than changes in any one gene; further, we made 
sure that effects were repeated across different treatments and/or 
different times; even for individual genes, there were multiple probes 
and multiple spots on a given array (see Methods), so the changes 
cannot be “chance.” Indeed, one of the key points of this study is to 
demonstrate that a planned comparisons approach may provide a 
superior strategy for the use of microarray data, provided that the 
relevant target pathways can be selected in advance, based on specific 
hypothesis and prior data. 
Our findings strengthen the view that, despite their common 
characteristic as cholinesterase inhibitors, organophosphates differ in 
their underlying mechanisms of developmental neurotoxicity, in this 
case involving glutamate. The dichotomy between the effects of 
chlorpyrifos and diazinon on glutamate transporter genes and on the 
cystine/glutamate exchanger are likely to play an important role in the 
greater susceptibility of developing neurons to chlorpyrifos-induced 
excitotoxicity [44,54], and ultimately in the different patterns of 
synaptic damage and behavioral deficits seen with each agent 
[39,43,45–48,50,51,56,61,65]. At the same time, we found surprising 
concordance in the effects of diazinon with unrelated neurotoxicants, 
dieldrin and Ni2+, indicating these dissimilar compounds nonetheless 
converge on common final pathways of neurotoxicity. These results 
with an in vitro system can thus guide future in vivo studies to 
evaluate the role of excitatory mechanisms in the developmental 
neurotoxicity of organophosphates and other toxicants and to design 
appropriate treatments that may protect the developing brain from 
injury. 
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